Published in Mol Immunol on October 01, 1984
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol (2001) 4.98
The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (1994) 2.53
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol (1974) 2.23
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol (1999) 2.05
A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today (1993) 2.02
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
CD40 ligand has potent antiviral activity. Nat Med (1995) 1.64
Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med (1990) 1.56
Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol (1990) 1.52
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol (1996) 1.52
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Lysis of herpesvirus-infected cells by immune spleen cells. Infect Immun (1975) 1.32
Particulate glucan synthetase activity: dependence on acceptor, activator, and plant growth hormone. Can J Biochem (1971) 1.24
Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci U S A (1991) 1.22
Broth and agar hop-gradient plates used to evaluate the beer-spoilage potential of Lactobacillus and Pediococcus isolates. Int J Food Microbiol (2009) 1.22
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med (1984) 1.20
Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol (1991) 1.16
Solid-phase radioimmunoassay of serum immunoglobulin A antibodies to respiratory syncytial virus and adenovirus. J Clin Microbiol (1979) 1.13
Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod (1998) 1.12
Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol (1994) 1.12
DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol Cell Biol (1997) 1.11
Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer (1987) 1.11
Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients. J Clin Microbiol (1994) 1.08
Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis (1981) 1.04
Further characterization of the anti-encephalitogenic protein (SCP): isolation from bovine spinal cord and spinal roots. J Immunol (1976) 1.04
Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol (1995) 1.03
Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res (1988) 1.03
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev (1999) 1.02
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology (1996) 1.01
OC43 strain-related coronavirus antibodies in different age groups. J Med Virol (1979) 1.01
Measles virus polypeptides in purified virions and in infected cells. Acta Pathol Microbiol Scand B (1978) 1.01
Particulate glucan synthetase activity: generation and inactivation after treatments with indoleacetic acid and cycloheximide. Arch Biochem Biophys (1972) 1.00
Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice. Eur J Immunol (1977) 1.00
Recombinant viruses as vaccines and immunological tools. Curr Opin Immunol (1997) 1.00
Determination of human immunoglobulin M rheumatoid factor by a solid-phase radioimmunoassay which uses human immunoglobulin G in antigen-antibody complexes. J Clin Microbiol (1978) 0.98
Studies on brain antigens. VI. Prevention of experimental allergic encephalomyelitis by a water-soluble spinal cord protein, 1 -SCP. J Immunol (1973) 0.98
Solid-phase enzyme immunoassay of bovine antibody responses following immunization against and natural infection with Pasteurella haemolytica. Vet Immunol Immunopathol (1983) 0.96
Studies on brain antigens. I. Water soluble antigenic proteins of rat brain. J Immunol (1966) 0.96
The use of bacteriophages to differentiate serologically cross-reactive isolates of Klebsiella pneumoniae. J Med Microbiol (1994) 0.93
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol (1999) 0.92
Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology (1982) 0.92
Studies on brain antigens. V. Purification and partial characterization of an anti-encephalitogenic spinal cord protein (SCP). J Immunol (1972) 0.90
Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity. Clin Exp Metastasis (1990) 0.90
A requirement for helper T cells in the induction of delayed-type hypersensitivity. J Immunol (1983) 0.90
IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J Immunol (1994) 0.90
A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Scand J Immunol (2004) 0.90
Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res (1992) 0.90
T-cell mediated immunity towards antigen(s) on isologous erythrocytes. Nature (1977) 0.88
A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol (1996) 0.88
Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins. Nature (1977) 0.88
Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus. Appl Microbiol (1971) 0.87
[Solid-phase radioimmunoassay for class specific immunoglobulins against tick-borne encephalitis virus (author's transl)]. Immun Infekt (1978) 0.87
Solid-phase enzyme immunoassay of IgM-class rheumatoid factor: comparison of three methods for preparation of the solid-phase target IgG. Acta Pathol Microbiol Scand C (1980) 0.87
Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines. Invasion Metastasis (1987) 0.86
IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand J Immunol (2002) 0.86
Cytokines in innate and adaptive immunity. Rev Immunogenet (2000) 0.86
Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J Natl Cancer Inst (1990) 0.85
The in vitro induction of T cells which mediate delayed-type hypersensitivity toward horse red blood cells. Cell Immunol (1979) 0.85
Involvement of plasminogen activator production with tumor metastasis in a rat model. Cancer Res (1984) 0.85
Stimulation of lymphocytes from subacute sclerosing panencephalitis patients by defined measles virus antigens. Cell Immunol (1980) 0.84
Real-time PCR detection of bacteria belonging to the Firmicutes Phylum. Int J Food Microbiol (2008) 0.84
Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod Fertil Dev (1994) 0.84
Surface properties of cells involved in antibody-dependent cytotoxicity. Cell Immunol (1976) 0.83
Studies on brain antigens. IV. Isolation and partial characterization of a rat species-restricted antigen of nervous tissue (SRANT). J Immunol (1970) 0.83
The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer (1983) 0.83
Isolation and further characterization of the anti-encephalitogenic rat spinal cord protein from brain, spinal cord and peripheral nerves. Biochim Biophys Acta (1981) 0.83
A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic. Int J Cancer (1982) 0.83
Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms. Scand J Immunol (1992) 0.82
Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol (1983) 0.82
Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Invasion Metastasis (1984) 0.82
Detection of Pediococcus spp. in brewing yeast by a rapid immunoassay. Appl Environ Microbiol (1992) 0.82
DNA immunization. Immunol Cell Biol (1997) 0.82
Circulating immune complexes in patients with acute measles and rubella virus infections. Infect Immun (1983) 0.81
Adherent cells suppress measles and herpes simplex I virus-induced blastogenesis of multiple sclerosis lymphocytes. J Neuroimmunol (1985) 0.81
Porcine C1q and the solid-phase immunoassay of human immune complexes. J Immunol Methods (1982) 0.81
The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor. Cytokine (1995) 0.81
IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients. J Neurol Sci (1981) 0.81
Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma. Cancer Res (1984) 0.81
Effect of an iron-chelating agent on lymphocyte proliferation. Aust J Exp Biol Med Sci (1984) 0.81
Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases. Acta Neurol Scand (1982) 0.80
Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clin Exp Immunol (1990) 0.80
Immunotherapy of equine cutaneous lymphosarcome using low dose cyclophosphamide and autologous tumor cells infected with vaccinea virus. Can Vet J (1993) 0.80
Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid. Functional analysis of the inflammatory process. J Neuroimmunol (1981) 0.80
Induction of delayed-type hypersensitivity to measles virus in mice. Cell Immunol (1984) 0.80
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma. J Med Primatol (2000) 0.80
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Parital characterization of the rat anti-encephalitogenic protein (RSCP). J Immunol (1976) 0.79
Immunology cross-reactivity between spinal cord protein and myelin basic protein. Int Arch Allergy Appl Immunol (1982) 0.79
Evidence that rat peripheral myelin does not contain the rat spinal cord protein (RSCP-PN). Neurosci Lett (1980) 0.79
Cyclophosphamide and dimethyl dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunology (1986) 0.79
Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series. Clin Exp Immunol (1981) 0.79
A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques. Vaccine (2000) 0.79
Immune response of rats to subcellular fractions of isologous brain and liver. Immunology (1971) 0.78